Table 5.
Female | Male | P value for treatment effect | ||||||
---|---|---|---|---|---|---|---|---|
CON | FGRS | FGRI | CON | FGRS | FGRI | |||
n = 15 | n = 16 | n = 13 | n = 22 | n = 12 | n = 17 | Female | Male | |
GV0‐1 WT | 53.6 ± 3.4 | 62.1 ± 3.2 | 55.6 ± 4.0 | 52.6 ± 2.0 | 62.4 ± 2.4 | 58.3 ± 3.1 | 0.08 | 0.04* |
GV0‐1 CRL | 2.0 ± 0.2 | 1.6 ± 0.2 | 1.9 ± 0.2 | 1.7 ± 0.2 | 1.6 ± 0.2 | 1.7 ± 0.2 | ns | ns |
GV1‐2 WT | 41.2 ± 3.4 | 49.3 ± 2.2 | 44.2 ± 2.5 | 40.4 ± 1.4 | 41.7 ± 1.8 | 45.6 ± 1.7 | 0.009* | 0.02† |
GV1‐2 CRL | 1.2 ± 0.2 | 1.9 ± 0.2 | 1.5 ± 0.2 | 1.6 ± 0.1 | 1.6 ± 0.1 | 1.6 ± 0.1 | 0.002* | ns |
Growth velocity (GV) in the first (GV0‐1) and second (GV1‐2) week after birth for body weight (WT; g kg−1 day−1) and crown–rump length (CRL; cm m−1 day−1). Data are means ± SEM. Symbols denote significant differences amongst experimental groups on post hoc testing: *CON vs. FGRS; †CON vs. FGRI; ns, not significant.